A selective inhibitor of the rho kinase pathway, y-27632, and its influence on wound healing in the corneal stroma

Molecular Vision

Volumn 18, Issue , 2012, Pages 1727-1739

  Yamamoto, Mayumi ^a,b   Quantock, Andrew J ^b,c   Young, Robert D ^b   Okumura, Naoki ^a   Ueno, Morio ^c   Sakamoto, Yuji ^a   Kinoshita, Shigeru ^c   Koizumi, Noriko ^a  

^a DOSHISHA UNIVERSITY   (Japan)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN FIBRIL; COLLAGEN GEL; COLLAGEN TYPE 1; COLLAGEN TYPE 2; COLLAGEN TYPE 3; KERATAN SULFATE; PROTEOGLYCAN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORNEA CELL; CORNEA INJURY; CORNEA STROMA; CORNEA THICKNESS; DRUG MECHANISM; ELECTRON MICROSCOPY; EXPERIMENTAL RABBIT; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; KERATECTOMY; MALE; MYOFIBROBLAST; NONHUMAN; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; SCAR FORMATION; SIGNAL TRANSDUCTION; SPINDLE CELL; WESTERN BLOTTING; WOUND HEALING;

ACTINS; AMIDES; ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; CICATRIX; COLLAGEN; CORNEAL KERATOCYTES; CORNEAL STROMA; ENZYME INHIBITORS; GELS; GENE EXPRESSION; KERATAN SULFATE; MALE; MYOFIBROBLASTS; OPHTHALMIC SOLUTIONS; OPHTHALMOLOGIC SURGICAL PROCEDURES; PYRIDINES; RABBITS; RHO-ASSOCIATED KINASES; TRANSFORMING GROWTH FACTOR BETA1; WOUND HEALING;

EID: 84864291003     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Hay ED. Development of vertebrate cornea. Int Rev Cytol 1980; 63:263-322. [PMID: 395131]
2. Jester JV, Huang J, Barry-Lane PA, Kao WW-Y, Petroll WM, Cavanagh HD. Transforming growth factorß-mediated corneal myofibroblast differentiation requires actin and fibronectin assembly. Invest Ophthalmol Vis Sci 1999; 40:1959-67.[PMID: 10440249]
3. Netto MV, Mohan RR, Ambrosio R Jr, Hutcheon AE, Zieske JD, Wilson SE. Wound healing in the cornea: a review of refractive surgery complications and new prospects for therapy. Cornea 2005; 24:509-22.[PMID: 15968154]
4. West-Mays JA, Dwivedi DJ. The keratocyte: corneal stromal cell with variable repair phenotypes. Int J Biochem Cell Biol 2006; 38:1625-31.[PMID: 16675284]
5. Gabbiani G, Ryan GB, Majno G. Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction. Experientia 1971; 27:549-50.[PMID: 5132594]
6. Gabbiani G, Hirschel BJ, Ryan GB, Statkov PR, Majno G. Granulation tissue as a contractile organ. A study of structure and function. J Exp Med 1972; 135:719-34.[PMID: 4336123]
7. Darby I, Skalli O, Gabbiani G. Alpha-smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing. Lab Invest 1990; 63:21-9. [PMID: 2197503]
8. Desmoulière A, Rubbia-Brandt L, Abdiu A, Walz T, Macieira-Coelho A, Gabbiani G. Alpha-smooth muscle actin is expressed in a subpopulation of cultured and cloned fibroblast and is modulated by gamma-interferon. Exp Cell Res 1992; 201:64-73.[PMID: 1612128]
9. Garana RM, Petroll WM, Chen WT, Herman IM, Barry P, Andrews P, Cavanagh HD, Jester JV. Radial keratectomy. II. Role of the myofibroblast in corneal wound contraction. Invest Ophthalmol Vis Sci 1992; 33:3271-82.[PMID: 1428702]
10. Jester JV, Petroll WM, Cavanagh HD. Corneal stromal wound healing in refractive surgery: the role of myofibroblasts. Prog Retin Eye Res 1999; 18:311-56.[PMID: 10192516]
11. Saika S. TGF-β signal transduction in corneal wound healing as a therapeutic target. Cornea 2004; 23:S25-30.[PMID: 15448476]
12. Saika S. TGFβ pathobiology in the eye. Lab Invest 2006; 86:106-15.[PMID: 16341020]
13. Wilson SE, Lloyd SA, He YG. EGF, basic FGF and TGF beta-1 messenger RNA production in rabbit corneal epithelial cells. Invest Ophthalmol Vis Sci 1992; 3:1987-95.[PMID: 1582803]
14. Wilson SE, Schultz GS, Chegini N, Weng J, He YG. Epidermal growth factor, transforming growth factor alpha, transforming growth factor beta, acidic fibroblast growth factor, basic fibroblast growth factor and interleukin-1 proteins in the cornea. Exp Eye Res 1994; 59:63-71.[PMID: 7530663]
15. Nishida K, Kinoshita S, Yokoi N, Kaneda M, Hashimoto K, Yamamoto S. Immunohistochemical localization of transforming growth factor-beta 1, -beta 2 and -beta 3 latencyassociated peptide in human cornea. Invest Ophthalmol Vis Sci 1994; 35:3289-94.[PMID: 8045718]
16. Nishida K, Sotozono C, Adachi W, Yamamoto S, Yokoi N, Kinoshita S. Transforming growth factor-beta 1, -beta 2 and -beta 3 mRNA expression in human cornea. Curr Eye Res 1995; 14:235-41.[PMID: 7796607]
17. Sano Y, Harada J, Tashiro S, Gotoh-Mandeville R, Maekawa T, Ishii S. ATF-2 is a common nuclear target of Smad and TAK1 pathways in transforming growth factor-β signaling. J Biol Chem 1999; 274:8949-57.[PMID: 10085140]
18. Bhowmick NA, Ghiassi M, Bakin A, Aakre M, Lundquist CA, Engel ME, Arteaga CL, Moses HL. Transforming growth factor-? mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Mol Biol Cell 2001; 12:27-36.[PMID: 11160820]
19. Ten Dijke P, Goumans M-J, Itoh F, Itoh S. Regulation of cell proliferation by Smad proteins. J Cell Physiol 2002; 191:1-16.[PMID: 11920677]
20. Wang W, Zhou G, Hu MC, Yao Z, Tan TH. Activation of the hematopoietic progenitor kinase-1 (HPK1)-dependent, stress-activated c-Jun N-terminal kinase (JNK) pathway by transforming growth factor β (TGF-β)-activated kinase (TAK1), a kinase mediator of TGF β signal transduction. J Biol Chem 1997; 272:22771-5.[PMID: 9278437]
21. Engel ME, McDonnell MA, Law BK, Moses HL. Interdependent SMAD and JNK signaling in transforming growth factor-β-mediated transcription. J Biol Chem 1999; 274:37413-20.[PMID: 10601313]
22. Dumont N, Bakin AV, Arteaga CL. Autocrine transforming growth factor-β signaling mediates Smad-independent motility in human cancer cells. J Biol Chem 2003; 278:3275-85.[PMID: 12421823]
23. Cocolakis E, Lemay S, Ali S, Lebrun JJ. The p38 MAPK pathway is required for cell growth inhibition of human breast cancer cells in response to activin. J Biol Chem 2001; 276:18430-6.[PMID: 11278744]
24. Petritsch C, Beug H, Balmain A, Oft M. TGF-β inhibits p70 S6 kinase via protein phosphatase 2A to induce G(1) arrest. Genes Dev 2000; 14:3093-101.[PMID: 11124802]
25. Gotzmann J, Huber H, Thallinger C, Wolschek M, Jansen B, Schulte-Hermann R, Beug H, Mikulits W. Hepatocytes convert to a fibroblastoid phenotype through the cooperation of TGF-β1 and Ha-Ras: steps towards invasiveness. J Cell Sci 2002; 115:1189-202.[PMID: 11884518]
26. Peron P, Rahmani M, Zagar Y, Durand-Schneider AM, Lardeux B, Bernuau D. Potentiation of Smad transactivation by Jun proteins during a combined treatment with epidermal growth factor and transforming growth factor-β in rat hepatocytes. Role of phosphatidylinositol 3-kinase-induced AP-1 activation. J Biol Chem 2001; 276:10524-31.[PMID: 11134003]
27. Chen J, Guerriero E, Sado Y, SundarRaj N. Rho-mediated regulation of TGF-beta1- and FGF-2-induced activation of corneal stromal keratocytes. Invest Ophthalmol Vis Sci 2009; 50:3662-70.[PMID: 19324862]
28. Koyanagi M, Takahashi J, Arakawa Y, Doi D, Fukuda H, Hayashi H, Narumiya S, Hashimoto N. Inhibition of the Rho/ ROCK pathway reduces apoptosis during transplantation of embryonic stem cell-derived neural precursors. J Neurosci Res 2008; 86:270-80.[PMID: 17828770]
29. Itoh K, Yoshioka K, Akedo H, Uehata M, Ishizaki T, Narumiya S. An essential part for Rho-associated kinase in the transcellular invasion of tumor cells. Nat Med 1999; 5:221-5.[PMID: 9930872]
30. Okumura N, Ueno M, Koizumi N, Sakamoto Y, Hamuro J, Kinoshita S. Enhancement on primate corneal endothelial cell survival in vitro by a ROCK inhibitor. Invest Ophthalmol Vis Sci 2009; 50:3680-7.[PMID: 19387080]
31. Nagatoya K, Moriyama T, Kawada N, Takeji M, Oseto S, Murozono T, Ando A, Imai E, Hori M. Y-27632 prevents tubulointerstitial fibrosis in mouse kidneys with unilateral ureteral obstruction. Kidney Int 2002; 61:1684-95.[PMID: 11967018]
32. Watanabe K, Ueno M, Kamiya D, Nishiyama A, Matsumura M, Wataya T, Takahashi JB, Nishikawa S, Muguruma K, Sasai Y. A ROCK inhibitor permits survival of dissociated human embryonic stem cells. Nat Biotechnol 2007; 25:681-6.[PMID: 17529971]
33. Ishizaki T, Uehata M, Tamechika I, Kell J, Nonomura K, Maekawa M, Narumiya S. Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases. Mol Pharmacol 2000; 57:976-83.[PMID: 10779382]
34. Cintron C, Covington HI, Kublin CL. Morphologic analyses of proteoglycans in rabbit corneal scars. Invest Ophthalmol Vis Sci 1990; 31:1789-98.[PMID: 2120145]
35. Rawe IM, Tuft SJ, Meek KM. Proteoglycan and collagen morphology in superficially scarred rabbit cornea. Histochem J 1992; 24:311-8.[PMID: 1634370]
36. Kita T, Hata Y, Arita R, Kawahara S, Miura M, Nakao S, Mochizuki Y, Enaida H, Goto Y, Shimokawa H, Hafesi- Moghadam A, Ishibashi T. Role of TGF-beta in proliferative vitreoretinal diseases and ROCK as a therapeutic target. Proc Natl Acad Sci USA 2008; 105:17504-9.[PMID: 18952846]
37. Scott JE. Collagen-proteoglycan interactions. Localization of proteoglycans in tendon by electron microscopy. Biochem J 1980; 187:887-91.[PMID: 7188429]
38. Scott JE, Orford CR. Dermatan sulphate-rich proteoglycan associates with rat tail-tendon collagen at the d band in the gap region. Biochem J 1981; 197:213-6.[PMID: 7317031]
39. Young RD. The ultrastructural organization of proteoglycans and collagen in human and rabbit scleral matrix. J Cell Sci 1985; 74:95-104.[PMID: 4030913]
40. Sullivan KM, Lorenz HP, Meuli M, Lin RY, Adzick NS. A model of scarless human fetal wound repair is deficient in transforming growth factor beta. J Pediatr Surg 1995; 30:198-202.[PMID: 7738738]
41. Shah M, Foreman DM, Ferguson MW. Control of scarring in adult wounds by neutralising antibody to transforming growth factorβ. Lancet 1992; 339:213-4.[PMID: 1346175]
42. Daniels JT, Schultz GS, Blalock TD, Garrett Q, Grotendorst GR, Dean NM, Khaw PT. Mediation of transforming growth factor-beta(1)-stimulated matrix contraction by fibroblasts: a role for connective tissue growth factor in contractile scarring. Am J Pathol 2003; 163:2043-52.[PMID: 14578203]
43. Garrett Q, Khaw PT, Blalock TD, Schultz GS, Grotendorst GR, Daniels JT. Involvement of CTGF in TGF-beta1-stimulation of myofibroblast differentiation and collagen matrix contraction in the presence of mechanical stress. Invest Ophthalmol Vis Sci 2004; 45:1109-16.[PMID: 15037576]
44. Newsome DA, Gross J, Hassell JR. Human corneal stroma contains three distinct collagens. Invest Ophthalmol Vis Sci 1982; 22:376-81.[PMID: 6277819]
45. Marshall GE, Konstas AG, Lee WR. Immunogold fine structural localization of extracellular matrix components in aged human cornea. I. Types I-IV collagen and laminin. Graefes Arch Clin Exp Ophthalmol 1991; 229:157-63.[PMID: 2044978]
46. Newsome DA, Foidart JM, Hassell JR, Krachmer JH, Rodrigues MM, Katz SI. Detection of specific collagen types in normal and keratoconus corneas. Invest Ophthalmol Vis Sci 1981; 20:738-50.[PMID: 7016805]
47. Melles GRJ, SundarRaj N, Binder PS, van der Weiden MM, Wijdh RH, Beekhuis WH, Anderson JA. Immunohistochemical analysis of unsutured and sutured corneal wound-healing. Curr Eye Res 1995; 14:809-17.[PMID: 8529420]
48. Ljubimov AV, Alba SA, Burgeson RE, Ninomiya Y, Sado Y, Sun TT, Nesburn AB, Kenney MC, Maguen E. Extracellular matrix changes in human corneas after radial keratotomy. Exp Eye Res 1998; 67:265-72.[PMID: 9778407]
49. Kato T, Nakayasu K, Kanai A. Corneal wound healing: immunohistological features of extracellular matrix following penetrating keratoplasty in rabbits. Jpn J phthalmol 2000; 44:334-41.[PMID: 10974287]
50. Mehmet H, Scudder P, Tang PW, Hounsell EF, Caterson B, Feizi T. The antigenic determinants recognized by three monoclonal antibodies to keratan sulfate involve hepta or larger oligosaccharides of the poly (N-acetyllactosamine) series. Eur J Biochem 1986; 157:385-91.[PMID: 2423332]
51. Liles M, Palka BP, Harris A, Kerr B, Hughes C, Young RD, Meek KM, Caterson B, Quantock AJ. Differential relative sulfation of keratan sulfate glycosaminoglycan in the chick cornea during embryonic development. Invest Ophthalmol Vis Sci 2010; 51:1365-72.[PMID: 19815728]
52. Young RD, Tudor D, Hayes AJ, Kerr B, Hayashida Y, Nishida K, Meek KM, Caterson B, Quantock AJ. Atypical composition and ultrastructure of proteoglycans in the mouse corneal stroma. Invest Ophthalmol Vis Sci 2005; 46:1973-8.[PMID: 15914611]
53. Kinoshita S, Adachi W, Sotozono C, Nishida K, Yokoi N, Quantock AJ, Okubo K. Characteristics of the human ocular surface epithelium. Prog Retin Eye Res 2001; 20:639-73.[PMID: 11470454]
54. Anderson SC, Stone C, Tkach L, SundarRaj N. Rho and Rhokinase (ROCK) signaling in adherens and gap junction assembly in corneal epithelium. Invest Ophthalmol Vis Sci 2002; 43:978-86.[PMID: 11923237]
55. Chen J, Guerriero E, Lathrop K, SundarRaj N. Rho/ROCK signaling in regulation of corneal epithelial cell cycle progression. Invest Ophthalmol Vis Sci 2008; 49:175-83.[PMID: 18172090]
56. Yin J, Yu FS. Rho kinases regulate corneal epithelial wound healing. Am J Physiol Cell Physiol 2008; 295:C378-87.[PMID: 18495812]
57. Wilson SE, Mohan RR, Mohan RR, Ambrósio R Jr, Hong J, Lee J. The corneal wound healing response: cytokinemediated interaction of the epithelium, stroma, and inflammatory cells. Prog Retin Eye Res 2001; 20:625-37.[PMID: 11470453]
58. Canty EG, Lu Y, Meadows RS, Shaw MK, Holmes DF, Kadler KE. Coalignment of plasma membrane channels and protrusions (fibripositors) specifies the parallelism of tendon. J Cell Biol 2004; 165:553-63.[PMID: 15159420]
59. Birk DE, Trelstad RL. Extracellular compartments in matrix morphogenesis: collagen fibril, bundle, and lamellar formation by corneal fibroblasts. J Cell Biol 1984; 99:2024-33.[PMID: 6542105]